Shipchain
MARCH 17, 2020
The activity of Chinese manufacturing plants has fallen in the past month and is expected to remain depressed for months.” . Although initially compared to the SARS outbreak, Coronavirus seems to be hitting much harder and much more quickly than the 2003 epidemic. And according to AXIOS , U.S.
QAD
OCTOBER 5, 2023
The state of manufacturing in 2023 is mixed. While we have no influence over natural disasters and geopolitical unrest, there’s another factor that has captured America’s attention in healthcare, food service, entertainment, distribution and, yes, manufacturing: labor disputes. To answer that question, I’d like to take a small detour.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Enterra Insights
MAY 4, 2020
.”[5] Extended global supply chains are being questioned as is a heavy reliance on Chinese manufacturing. Tan points out, when the SARS, or severe acute respiratory syndrome, epidemic broke out in 2002 and 2003, “China contributed 4% to the world’s GDP. Step 5 : Book logistics capacity as soon as possible.
Jaggaer
FEBRUARY 12, 2020
Since the outbreak of SARS in 2003, the last major epidemic to hit China, the country has become even more important as a source of key components and materials as well as finished consumer goods. China ’ s economy has grown in leaps and bounds from roughly 4% of world GDP in 2003 to 1 6% today. Telecommunications equipment.
NC State SCRC
MAY 27, 2020
The plan also call for a dramatic expansion in the materials held in the SNS, to cover sufficient reserves of 100 percent of major items associated with COVID-like pandemics, has access to predictive analytics for forecast requirements and enhances domestic manufacturing capacity to reduce the country’s dependence on foreign sources of supply.
SCMDOJO
FEBRUARY 29, 2024
However, all assessments will assess providers of aspects such as financing, production capacity and facilities, human resources, quality, performance, environmental and ethical considerations, and IT. Attention should be paid to the following aspects: Does the supplier have a full range of machinery to manufacture the required product?
Supply Chain View from the Field
AUGUST 8, 2013
The company discovers, develops, manufactures, and markets biological products for treating conditions such as multiple sclerosis and non-Hodgkin’s lymphoma. It was formed from the November 2003 merger of Biogen, Inc. and IDEC Pharmaceuticals Corp. Several factors had converged to spark the maturity assessment.
Expert insights. Personalized for you.
106 
Let's personalize your content